| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 77,834 | 92,411 | 87,363 | 90,352 | | Cost of Revenue | 43,804 | 53,316 | 50,318 | 53,012 | | | Gross Profit | 34,030 | 39,095 | 37,045 | 37,340 | | | Operating Expenses | | Research Development | 6,604 | 7,157 | 6,749 | 7,145 | | Selling General and Administrative | 11,673 | 13,444 | 13,250 | 14,326 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,534 | 1,595 | 1,781 | 1,947 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,219 | 16,899 | 15,265 | 13,922 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 175 | 280 | 255 | 369 | | Earnings Before Interest And Taxes | 14,394 | 17,179 | 15,520 | 14,291 | | Interest Expense | 94 | 94 | 95 | 95 | | Income Before Tax | 14,300 | 17,085 | 15,425 | 14,196 | | Income Tax Expense | 5,372 | 6,068 | 5,819 | 3,732 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,928 | 11,017 | 9,606 | 10,464 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,928 | 11,017 | 9,606 | 10,464 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,928 | $11,017 | $9,606 | $10,464 |
|
0.51% Nasdaq 
Income Statement
